Search results

42 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Narrowing the gap toward precision medicine for pancreatic cancer
To improve treatment and our understanding of one of the deadliest cancers in the United States, UNC Lineberger's Jen Jen Yeh, MD, was involved in two studies that take different approaches to precision medicine for pancreatic cancer.
Located in News
Skin cancer treatment selfie goes viral, has public health lessons
Researchers led by UNC Lineberger's Seth Noar, PhD, analyzed the impact of one viral social media post in generating awareness about skin cancer.
Located in News
Using software, researchers predict tumor markers that could be immune targets
UNC Lineberger researchers led by Benjamin Vincent, MD, reported preliminary findings at the 59th American Society for Hematology Annual Meeting in Atlanta that are an early step in the overall plan to use the software’s predictions to develop immune-based therapies for leukemia.
Located in News
Biological factors don't completely explain racial disparities for ‘good prognosis’ breast cancer
The biological features of patients’ tumors partially explained a racial disparity for women with hormone receptor-positive, HER2-negative breast cancer, but UNC Lineberger researchers led by Katherine Reeder-Hayes, MD, MBA, MSc, said it didn’t explain it completely. The preliminary findings were reported at the 2017 San Antonio Breast Cancer Symposium.
Located in News
NCI grant to help more cancer patients become tobacco-free
A grant from the National Cancer Institute will help expand tobacco cessation programs for cancer patients at the N.C. Cancer Hospital.
Located in News
Timing could matter to how responsive cancer cells are to treatment, study suggests
In a new study published in Cell Systems, UNC Lineberger's Jeremy Purvis, PhD, and colleagues report that the timing of when DNA damage occurs within these different checkpoints matters to a cell’s fate.
Located in News
Using new knowledge about cell division, researchers look to improve chemotherapy effects
A study led by UNC Lineberger member Michael J. Emanuele, PhD, was featured on the cover of The Journal of Biological Chemistry. The researchers uncovered new details about a protein called NUSAP1 during chromosome segregation, and offered a possible way to sensitize cancer cells to a particular type of chemotherapy.
Located in News
To improve melanoma treatment, researchers look to block deletion of ‘self-reactive’ immune cells
UNC Lineberger researchers led by Maureen Su, MD, report on a potential new way to fight melanoma by blocking one of the immune system’s checks and balances.
Located in News
Located in Newsroom / UNC Lineberger in the News
Innovative cancer data resource expands, gains a new name
Academics and policymakers are using the Cancer Information & Population Health Resource, or CIPHR, to knit together data from multiple public and private sources to examine a wide range of complex issues tied to improving cancer outcomes in North Carolina.
Located in News